{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:01:53Z","timestamp":1761807713716},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1331\/japha.2011.10094","type":"journal-article","created":{"date-parts":[[2011,11,9]],"date-time":"2011-11-09T02:05:35Z","timestamp":1320804335000},"page":"762-765","source":"Crossref","is-referenced-by-count":38,"title":["Student pharmacist perspectives on providing pharmacy-access hormonal contraception services"],"prefix":"10.1016","volume":"51","author":[{"given":"Sally","family":"Rafie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shareen Y.","family":"El-Ibiary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1331\/JAPhA.2011.10094_bb0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1363\/3809006","article-title":"Disparities in unintended pregnancy rates in 1994 and 2001","volume":"38","author":"Finer","year":"2006","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1331\/JAPhA.2011.10094_bb0015","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2105\/AJPH.2004.040774","article-title":"Barriers to contraceptive use in product labeling and practice guidelines","volume":"96","author":"Grossman","year":"2006","journal-title":"Am J Public Health"},{"key":"10.1331\/JAPhA.2011.10094_bb0020","author":"National Conference of State Legislatures","year":"2011","journal-title":"Emergency contraception state laws"},{"key":"10.1331\/JAPhA.2011.10094_bb0025","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1331\/JAPhA.2008.07138","article-title":"Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study","volume":"48","author":"Gardner","year":"2008","journal-title":"J Am Pharm Assoc."},{"key":"10.1331\/JAPhA.2011.10094_bb0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1331\/JAPhA.2007.06112","article-title":"Pharmacy and clinic partnerships to expand access to injectable contraception","volume":"47","author":"Monastersky Maderas","year":"2007","journal-title":"J Am Pharm Assoc"},{"key":"10.1331\/JAPhA.2011.10094_bb0035","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.contraception.2006.07.006","article-title":"Birth control within reach: a national survey on women's attitudes toward and interest in pharmacy access to hormonal contraception","volume":"74","author":"Landau","year":"2006","journal-title":"Contraception"},{"key":"10.1331\/JAPhA.2011.10094_bb0040","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1001\/jama.285.17.2232","article-title":"Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence","volume":"285","author":"Stewart","year":"2001","journal-title":"JAMA"},{"key":"10.1331\/JAPhA.2011.10094_bb0045","series-title":"U.S. Agency for International Development. Recommendations for updating selected practices in contraceptive use","volume":"Vol. 1","author":"World Health Organization","year":"1994"},{"key":"10.1331\/JAPhA.2011.10094_bb0050","article-title":"Labeling guidance text for combination oral contraceptives, prescribing information, physician labeling","author":"Food and Drug Administration","year":"1994"},{"key":"10.1331\/JAPhA.2011.10094_bb0055","series-title":"Guidelines for women's health care","author":"American College of Obstetricians and Gynecologists","year":"1996"},{"key":"10.1331\/JAPhA.2011.10094_bb0060","series-title":"Oral contraceptives for adolescents: benefits and safety","author":"American College of Obstetricians and Gynecologists","year":"1999"},{"key":"10.1331\/JAPhA.2011.10094_bb0065","series-title":"Manual of medical standards and guidelines: hormonal contraceptive use","author":"Planned Parenthood Federation of America","year":"1999"},{"key":"10.1331\/JAPhA.2011.10094_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1331\/JAPhA.2009.07154","article-title":"Pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States","volume":"49","author":"Landau","year":"2009","journal-title":"J Am Pharm Assoc"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115307354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115307354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T18:59:10Z","timestamp":1543431550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319115307354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1544319115307354"],"URL":"https:\/\/doi.org\/10.1331\/japha.2011.10094","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}